ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Premixed injection solutions are available and may help reduce dosage errors. For patients on diuretic therapy, the recommended starting dose is 0.625 mg administered over 5 minutes. [86] Clinical ...

His treatment, developed with David Nalin, was elegant in its simplicity, which made it accessible to people and countries ...

He worked alongside another doctor to show that a simple rehydration therapy could check the ravages of cholera and other ...

Daphne delivered her son, Raylon, three months early. He weighed one pound, 10 ounces, and required immediate and specialized ...

Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.

IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

In "Star Trek: Lower Decks"' latest mission, "A Farewell to Farms", Mariner and Boimler catch up with Mariner's old Klingon ...

Eisai (ESAIY) completes BLA submissions for an injectable version of its Biogen (BIIB)-partered Alzheimer's drug Leqembi in ...